Friday Courses
Receive in-depth updates on the latest in GI and hepatology, endoscopy, and practice management when you attend one or more of the optional Friday courses. Four courses are offered: three half-day courses, the GI Pathology and Imaging Course, the What’s New in GI Pharmacology Course, and the Practice Management Summit; and one full-day course, the ASGE Endoscopy Course.
What’s New in GI Pharmacology Course
Friday, October 25, 2024 | 1:45 pm – 5:20 pm Eastern Time
Course Directors: Brooks D. Cash, MD, FACG, and William D. Chey, MD, FACG
| Friday, October 25, 2024 │ ALL TIMES ARE LISTED IN THE EASTERN TIME ZONE | |
|---|---|
| 1:45 pm | Welcome and Introductions Brooks D. Cash, MD, FACG, and William D. Chey, MD, FACG |
| SESSION 1 Moderator: Brooks D. Cash, MD, FACG |
|
| 1:50 pm | GLP1 Agonists and GI Patients: What You Need to Know Now Michael Camilleri, MD, MACG Explain the mechanisms and management of GLP1-induced effects in gastroenterology and endoscopic practice. |
| 2:10 pm | Crohn’s Disease Pharmacologic Therapy: Where Do We Stand in 2024? Millie D. Long, MD, MPH, FACG Discuss the evidence and placement of current and future pharmacologic therapies for Crohn’s disease. |
| 2:30 pm | Causes and Solutions for High Ostomy Output Darrell S. Pardi, MD, MS, FACG Apply best evidence for the diagnosis and pharmacologic therapy of high ostomy output scenarios. |
| 2:50 pm | What’s New in Alcohol-Associated Liver Disease? Loretta L. Jophlin, MD, PhD Discuss the new ACG alcohol-associated liver disease guideline and identify currently available and emerging management strategies and outcomes for patients with alcoholic liver disease. |
| 3:10 pm | Q & A |
| 3:25 pm | Break |
| SESSION 2 Moderator: William D. Chey, MD, FACG |
|
| 3:40 pm | Identification and Management of Opioid-Induced Gastrointestinal Dysfunction Brooks D. Cash, MD, FACG Discuss the evaluation and management of opioid-induced and opioid- associated gastrointestinal symptoms. |
| 4:00 pm | Embracing Neuromodulators for Chronic Gastrointestinal Symptoms Lin Chang, MD, FACG Explain current best evidence supporting the use of neuromodulator therapies for GI disease and how to prescribe and monitor them. |
| 4:20 pm | 2024 Update in Helicobacter pylori Best Practices Shailja C. Shah, MD, MPH Identify the optimal strategies for managing Helicobacter pylori infection and review the updated ACG guideline. |
| 4:40 pm | Medical Management of Acute Pancreatitis Santhi Swaroop Vege, MD, MACG Describe the new ACG Acute Pancreatitis guideline and the newest information regarding the evaluation and pharmacologic management of acute pancreatitis. |
| 5:00 pm | Q & A |
| 5:20 pm | Course Adjourns |
